These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat. Cahir M; King DJ Eur Neuropsychopharmacol; 2005 Mar; 15(2):231-4. PubMed ID: 15695070 [TBL] [Abstract][Full Text] [Related]
4. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931 [TBL] [Abstract][Full Text] [Related]
6. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537 [TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Nasrallah HA Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919 [TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084 [TBL] [Abstract][Full Text] [Related]
10. Role of serotonin and dopamine receptor binding in antipsychotic efficacy. Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032 [TBL] [Abstract][Full Text] [Related]
11. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Leysen JE; Janssen PM; Megens AA; Schotte A J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908 [TBL] [Abstract][Full Text] [Related]
12. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. Bylund DB J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776 [TBL] [Abstract][Full Text] [Related]
13. Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action. Tsukamoto T; Asakura M; Hirata N; Imafuku J; Matsui H; Hasegawa K Biol Psychiatry; 1984 Sep; 19(9):1283-91. PubMed ID: 6149771 [TBL] [Abstract][Full Text] [Related]
14. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793 [TBL] [Abstract][Full Text] [Related]
15. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro. Perrone MH; Hamel LT; Ferrari RA; Haubrich DR J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637 [TBL] [Abstract][Full Text] [Related]
16. Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs. Ma J; Ye N; Cohen BM Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):647-57. PubMed ID: 16487641 [TBL] [Abstract][Full Text] [Related]
17. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain]. Matsubara R Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976 [TBL] [Abstract][Full Text] [Related]
18. Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors. Tanibuchi Y; Fujita Y; Kohno M; Ishima T; Takatsu Y; Iyo M; Hashimoto K Eur Neuropsychopharmacol; 2009 Dec; 19(12):861-7. PubMed ID: 19656663 [TBL] [Abstract][Full Text] [Related]
19. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects. Svartengren J; Pettersson E; Björk A Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901 [TBL] [Abstract][Full Text] [Related]
20. Priapism associated with atypical antipsychotic medications: a review. Sood S; James W; Bailon MJ Int Clin Psychopharmacol; 2008 Jan; 23(1):9-17. PubMed ID: 18090503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]